H.B. Fuller Company (NYSE: FUL) plans to report its third quarter fiscal 2026 financial results on September 23, 2026. The announcement is scheduled for release after the market close.

The company will hold an investor conference call on September 24, 2026, at 9:30 a.m. CT to discuss the results. Interested parties may listen to the call via a live webcast accessible through the company’s investor relations website.

Conference Call Details

Participants must register for the webcast at least 10 minutes prior to the start of the call to install and test necessary software. The webcast will be archived on the company’s website following the event.

A telephone replay of the conference call will be available from 12:30 p.m. CT on September 24, 2026, to 10:59 p.m. CT on October 1, 2026. To access the replay, dial 1-833-309-1852 (toll free) or 1-929-828-5978 and enter Meeting ID: 835696208.

About H.B. Fuller Company

H.B. Fuller is the largest pureplay adhesives company in the world. Founded in 1887, the company reported revenue of $3.5 billion in 2025. Its team of more than 7,100 global members operates across 150 countries and serves more than 30 market segments.

Ancora Holdings Group LLC reaffirmed its proposal to acquire H.B. Fuller Company’s (NYSE: FUL) Building Adhesive Solutions (BAS) segment on August 24, 2026, following the company’s board unanimous rejection of the offer.

The activist investor described the board’s decision as "baseless" and "irrational," stating that it learned of the rejection through media reports rather than direct outreach. Ancora emphasized that the proposal remains a win for shareholders and the company.

Conflict Over Valuation and Strategy

Ancora criticized the board for dismissing a "highly-credible proposal" without engagement. The investor group highlighted several points in its statement:

• Offer Flexibility: Ancora stated it is prepared to increase the contemplated offer if due diligence warrants a higher price.
• Financing Certainty: The acquisition can be completed without a financing contingency.
• Leverage Concerns: Ancora argued that asset sales are the most viable path for H.B. Fuller to address its leverage crisis, citing what it termed "extremely poor cash flow conversion."

Ancora also noted that H.B. Fuller has delivered negative total shareholder returns over every relevant period and produced sustained underperformance throughout its CEO's tenure. The investor group claimed that Board Chair Teresa Rasmussen's rejection letter appeared to be ghostwritten by advisors tasked with defending the status quo, citing a lack of direct engagement as evidence of entrenchment.

Board’s Previous Stance

H.B. Fuller’s board had previously rejected the unsolicited, non-binding proposal, citing significant undervaluation. The directors noted that the proposed value of $1.1 billion to $1.2 billion was substantially below precedent transactions.

Key factors supporting the board’s rejection included:

• Growth Prospects: The BAS segment reported second-quarter organic growth of 6% year-over-year and a 10% improvement in EBITDA.
• Operational Synergies: Carving out BAS would create inefficiencies due to shared manufacturing facilities across more than thirty global plants.
• Deleveraging Plan: The company aims to reduce leverage to a target range of 2.5x to 3.0x within two years post-AMS acquisition.

What the Numbers Show

A sharp divergence exists between the two parties regarding capital efficiency. While H.B. Fuller points to operational improvements in BAS, including EBITDA growth, Ancora challenges the credibility of the board’s deleveraging strategy. Ancora cited an abysmal five-year average free cash flow conversion rate of 28.1%, arguing that reliance on internal cash generation to reduce leverage is insufficient compared to asset divestiture.

Escalation Risks

Ancora warned that the board should be held liable if decisions result in continued harm to shareholders, threatening to pursue all available legal remedies. The investor group called for either capable leadership changes or a credible review of strategic alternatives to avoid a prolonged public campaign.